We are analyzing https://link.springer.com/article/10.1007/s10549-012-2397-6.

Title:
Racial differences in outcomes of triple-negative breast cancer | Breast Cancer Research and Treatment
Description:
African American (AA) women have a higher incidence of triple-negative breast cancer (TNBC: negative for the expression of estrogen receptor, progesterone receptor, and HER2 gene amplification) than Caucasian (CA) women, explaining in part their higher breast cancer mortality. However, there have been inconsistent data in the literature regarding survival outcomes of TNBC in AA versus CA women. We performed a retrospective chart review on 493 patients with TNBC first seen at the Washington University Breast Oncology Clinic (WUBOC) between January 2006 and December 2010. Analysis was done on 490 women (30 % AA) for whom follow-up data was available. The median age at diagnosis was 53 (23–98) years and follow-up time was 27.2 months. There was no significant difference between AA and CA women in the age of diagnosis, median time from abnormal imaging to breast biopsy and from biopsy diagnosis to surgery, duration of follow-up, tumor stage, grade, and frequency of receiving neoadjuvant or adjuvant chemotherapy and pathologic complete response rate to neoadjuvant chemotherapy. There was no difference in disease free survival (DFS) and overall survival (OS) between AA and CA groups by either univariate or multivariate analysis that included age, race, and stage. The hazard ratio for AA women was 1.19 (CI 0.80–1.78, p = 0.39) and 0.91 (CI 0.62–1.35, p = 0.64) for OS and DFS, respectively. Among the 158 patients who developed recurrence or presented with stage IV disease (AA: n = 36, CA: n = 122), no racial differences in OS were observed. We conclude that race did not significantly affect the clinical presentation and outcome of TNBC in this single center study where patients received similar therapy and follow-up.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Health & Fitness
Education
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

cancer, breast, article, google, scholar, pubmed, survival, women, cas, patients, race, triplenegative, differences, treatment, racial, outcomes, study, clin, chemotherapy, res, research, washington, university, medicine, privacy, cookies, content, analysis, data, american, tnbc, tumor, access, disparities, white, treat, oncol, usa, publish, search, gao, ellis, cynthia, african, negative, receptor, oncology, followup, diagnosis, stage,

Topics {✒️}

month download article/chapter called triple-negative phenotype triple-negative breast cancer single-institution compilation compared early-stage breast cancer newly diagnosed african-american single center study breast cancer prognosis retrospective chart review triple negative threats full article pdf siteman cancer center privacy choices/manage cookies randomized chemotherapy trial breast cancer subtypes breast cancer screening related subjects disease free survival stage iv disease washington university school breast carcinoma characteristics primary breast cancer national cancer institute her2 gene amplification event-free survival population-based study hospital-based study breast cancer survival breast cancer treatment complete pathologic response breast carcinoma survival california cancer registry breast cancer patients late-stage presentation european economic area end results database hmo-based intervention sledge gw jr conditions privacy policy tumor biologic factors health insurance coverage long-term survival improved survival compared accepting optional cookies post-hoc analysis heath cw jr factors influencing differences adjuvant tamoxifen therapy article log primary systemic treatment

Questions {❓}

Sachdev JC, Ahmed S, Mirza MM, Farooq A, Kronish L, Jahanzeb M (2010) Does race affect outcomes in triple negative breast cancer?
Smith-Bindman R, Miglioretti DL, Lurie N, Abraham L, Barbash RB, Strzelczyk J, Dignan M, Barlow WE, Beasley CM, Kerlikowske K (2006) Does utilization of screening mammography explain racial and ethnic differences in breast cancer?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Racial differences in outcomes of triple-negative breast cancer
         description:African American (AA) women have a higher incidence of triple-negative breast cancer (TNBC: negative for the expression of estrogen receptor, progesterone receptor, and HER2 gene amplification) than Caucasian (CA) women, explaining in part their higher breast cancer mortality. However, there have been inconsistent data in the literature regarding survival outcomes of TNBC in AA versus CA women. We performed a retrospective chart review on 493 patients with TNBC first seen at the Washington University Breast Oncology Clinic (WUBOC) between January 2006 and December 2010. Analysis was done on 490 women (30 % AA) for whom follow-up data was available. The median age at diagnosis was 53 (23–98) years and follow-up time was 27.2 months. There was no significant difference between AA and CA women in the age of diagnosis, median time from abnormal imaging to breast biopsy and from biopsy diagnosis to surgery, duration of follow-up, tumor stage, grade, and frequency of receiving neoadjuvant or adjuvant chemotherapy and pathologic complete response rate to neoadjuvant chemotherapy. There was no difference in disease free survival (DFS) and overall survival (OS) between AA and CA groups by either univariate or multivariate analysis that included age, race, and stage. The hazard ratio for AA women was 1.19 (CI 0.80–1.78, p = 0.39) and 0.91 (CI 0.62–1.35, p = 0.64) for OS and DFS, respectively. Among the 158 patients who developed recurrence or presented with stage IV disease (AA: n = 36, CA: n = 122), no racial differences in OS were observed. We conclude that race did not significantly affect the clinical presentation and outcome of TNBC in this single center study where patients received similar therapy and follow-up.
         datePublished:2013-02-12T00:00:00Z
         dateModified:2013-02-12T00:00:00Z
         pageStart:281
         pageEnd:289
         sameAs:https://doi.org/10.1007/s10549-012-2397-6
         keywords:
            Race
            Triple-negative breast cancer
            Outcome
            Retrospective study
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-012-2397-6/MediaObjects/10549_2012_2397_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-012-2397-6/MediaObjects/10549_2012_2397_Fig2_HTML.gif
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:138
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Jose M. Pacheco
               affiliation:
                     name:Washington University School of Medicine
                     address:
                        name:Department of Internal Medicine, Washington University School of Medicine, St. Louis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Feng Gao
               affiliation:
                     name:Washington University School of Medicine
                     address:
                        name:Division of Biostatistics, Washington University School of Medicine, St. Louis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Caroline Bumb
               affiliation:
                     name:Washington University School of Medicine
                     address:
                        name:Section of Breast Oncology, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Matthew J. Ellis
               affiliation:
                     name:Washington University School of Medicine
                     address:
                        name:Section of Breast Oncology, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, USA
                        type:PostalAddress
                     type:Organization
                     name:Washington University School of Medicine
                     address:
                        name:Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Cynthia X. Ma
               affiliation:
                     name:Washington University School of Medicine
                     address:
                        name:Section of Breast Oncology, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, USA
                        type:PostalAddress
                     type:Organization
                     name:Washington University School of Medicine
                     address:
                        name:Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Racial differences in outcomes of triple-negative breast cancer
      description:African American (AA) women have a higher incidence of triple-negative breast cancer (TNBC: negative for the expression of estrogen receptor, progesterone receptor, and HER2 gene amplification) than Caucasian (CA) women, explaining in part their higher breast cancer mortality. However, there have been inconsistent data in the literature regarding survival outcomes of TNBC in AA versus CA women. We performed a retrospective chart review on 493 patients with TNBC first seen at the Washington University Breast Oncology Clinic (WUBOC) between January 2006 and December 2010. Analysis was done on 490 women (30 % AA) for whom follow-up data was available. The median age at diagnosis was 53 (23–98) years and follow-up time was 27.2 months. There was no significant difference between AA and CA women in the age of diagnosis, median time from abnormal imaging to breast biopsy and from biopsy diagnosis to surgery, duration of follow-up, tumor stage, grade, and frequency of receiving neoadjuvant or adjuvant chemotherapy and pathologic complete response rate to neoadjuvant chemotherapy. There was no difference in disease free survival (DFS) and overall survival (OS) between AA and CA groups by either univariate or multivariate analysis that included age, race, and stage. The hazard ratio for AA women was 1.19 (CI 0.80–1.78, p = 0.39) and 0.91 (CI 0.62–1.35, p = 0.64) for OS and DFS, respectively. Among the 158 patients who developed recurrence or presented with stage IV disease (AA: n = 36, CA: n = 122), no racial differences in OS were observed. We conclude that race did not significantly affect the clinical presentation and outcome of TNBC in this single center study where patients received similar therapy and follow-up.
      datePublished:2013-02-12T00:00:00Z
      dateModified:2013-02-12T00:00:00Z
      pageStart:281
      pageEnd:289
      sameAs:https://doi.org/10.1007/s10549-012-2397-6
      keywords:
         Race
         Triple-negative breast cancer
         Outcome
         Retrospective study
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-012-2397-6/MediaObjects/10549_2012_2397_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-012-2397-6/MediaObjects/10549_2012_2397_Fig2_HTML.gif
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:138
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Jose M. Pacheco
            affiliation:
                  name:Washington University School of Medicine
                  address:
                     name:Department of Internal Medicine, Washington University School of Medicine, St. Louis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Feng Gao
            affiliation:
                  name:Washington University School of Medicine
                  address:
                     name:Division of Biostatistics, Washington University School of Medicine, St. Louis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Caroline Bumb
            affiliation:
                  name:Washington University School of Medicine
                  address:
                     name:Section of Breast Oncology, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Matthew J. Ellis
            affiliation:
                  name:Washington University School of Medicine
                  address:
                     name:Section of Breast Oncology, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, USA
                     type:PostalAddress
                  type:Organization
                  name:Washington University School of Medicine
                  address:
                     name:Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Cynthia X. Ma
            affiliation:
                  name:Washington University School of Medicine
                  address:
                     name:Section of Breast Oncology, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, USA
                     type:PostalAddress
                  type:Organization
                  name:Washington University School of Medicine
                  address:
                     name:Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:138
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Washington University School of Medicine
      address:
         name:Department of Internal Medicine, Washington University School of Medicine, St. Louis, USA
         type:PostalAddress
      name:Washington University School of Medicine
      address:
         name:Division of Biostatistics, Washington University School of Medicine, St. Louis, USA
         type:PostalAddress
      name:Washington University School of Medicine
      address:
         name:Section of Breast Oncology, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, USA
         type:PostalAddress
      name:Washington University School of Medicine
      address:
         name:Section of Breast Oncology, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, USA
         type:PostalAddress
      name:Washington University School of Medicine
      address:
         name:Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, USA
         type:PostalAddress
      name:Washington University School of Medicine
      address:
         name:Section of Breast Oncology, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, USA
         type:PostalAddress
      name:Washington University School of Medicine
      address:
         name:Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Jose M. Pacheco
      affiliation:
            name:Washington University School of Medicine
            address:
               name:Department of Internal Medicine, Washington University School of Medicine, St. Louis, USA
               type:PostalAddress
            type:Organization
      name:Feng Gao
      affiliation:
            name:Washington University School of Medicine
            address:
               name:Division of Biostatistics, Washington University School of Medicine, St. Louis, USA
               type:PostalAddress
            type:Organization
      name:Caroline Bumb
      affiliation:
            name:Washington University School of Medicine
            address:
               name:Section of Breast Oncology, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, USA
               type:PostalAddress
            type:Organization
      name:Matthew J. Ellis
      affiliation:
            name:Washington University School of Medicine
            address:
               name:Section of Breast Oncology, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, USA
               type:PostalAddress
            type:Organization
            name:Washington University School of Medicine
            address:
               name:Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, USA
               type:PostalAddress
            type:Organization
      name:Cynthia X. Ma
      affiliation:
            name:Washington University School of Medicine
            address:
               name:Section of Breast Oncology, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, USA
               type:PostalAddress
            type:Organization
            name:Washington University School of Medicine
            address:
               name:Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Internal Medicine, Washington University School of Medicine, St. Louis, USA
      name:Division of Biostatistics, Washington University School of Medicine, St. Louis, USA
      name:Section of Breast Oncology, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, USA
      name:Section of Breast Oncology, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, USA
      name:Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, USA
      name:Section of Breast Oncology, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, USA
      name:Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(128)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

4.52s.

LINK . SPRINGER . COM {}